We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Zink and Bone Strength

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00317863
Recruitment Status : Completed
First Posted : April 25, 2006
Last Update Posted : September 15, 2017
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Zink and bone strength

Condition or disease
Coxarthrosis Fracture of Femoral Neck

Detailed Description:
blood- and urine samples collected from 20 OA patients and 20 osteoporosis patients who all had a hip-replacement. All patients were evaluated by DEXA-scanning.

Study Design

Study Type : Observational
Actual Enrollment : 40 participants
Observational Model: Cohort
Time Perspective: Other
Official Title: Zink and Bone Strength
Actual Study Start Date : January 2004
Primary Completion Date : January 1, 2008
Study Completion Date : January 1, 2008

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
blood- and urine samples collected from 20 OA patients and 20 osteoporosis patients who all had a hip-replacement. All patients were evaluated by DEXA-scanning.
Criteria

Inclusion Criteria:

Postmenopausal women with osteoarthrosis or femoral neck-fracture i one hip

Exclusion Criteria:

pathology or prosthesis in contralateral hip

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00317863


Locations
Denmark
Northern Orthopaedic Division, Klinik Farsoe
Farsoe, Northern Jutland, Denmark
Sponsors and Collaborators
Northern Orthopaedic Division, Denmark
Investigators
Principal Investigator: Janne Ovesen, MD Northern Orthopaedic Division
More Information

Additional Information:
Responsible Party: Northern Orthopaedic Division, Denmark
ClinicalTrials.gov Identifier: NCT00317863     History of Changes
Other Study ID Numbers: ON-04-003-JO
First Posted: April 25, 2006    Key Record Dates
Last Update Posted: September 15, 2017
Last Verified: September 2017

Additional relevant MeSH terms:
Osteoarthritis, Hip
Osteoarthritis
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases